IL1B and stroke disorder: revealed that HF-rTMS on the affected dorsolateral prefrontal cortex (DLPFC) of stroke patients could significantly reduce the mRNA level of pro-inflammatory cytokines (IL-1β, IL-6, TGF-β, TNF-α) in blood samples, indicating the anti-inflammatory effect of rTMS (154).